Skip to content

Wegovy Heartburn & Acid Reflux: Clinical Data, Causes & How to Keep Them Under Control

Yes, Wegovy can cause heartburn and acid reflux, but most people don't get it. In clinical trials of Wegovy (semaglutide), 9% of adults had indigestion and 5% had acid reflux, compared with 3% each on placebo (Wegovy prescribing information). If it's happening to you, the pattern is usually easy to find once you look. Glapp, the GLP-1 tracker, lets you log heartburn right next to your Wegovy doses, so you can see which days it flares and whether it's calming down.

Key numbers

Number What it means
9% of adults on Wegovy had indigestion in its weight-loss trials, vs 3% on placebo
5,874 users currently tracking Wegovy-related heartburn or acid reflux in Glapp
5% had acid reflux (GERD), vs 3% on placebo

Wegovy acid reflux and indigestion: what the clinical evidence shows

Wegovy's prescribing information pools placebo-controlled weight-loss trials of semaglutide 2.4 mg in adults. Heartburn-related symptoms:

Side effect Placebo Wegovy 2.4 mg
Dyspepsia (indigestion)3%9%
Eructation (burping)<1%7%
Gastroesophageal reflux disease (acid reflux)3%5%
Gastritis1%4%

Source: Wegovy prescribing information, Table 3.

Indigestion was three times as common as on placebo. Heartburn as a single word isn't a separate row in the semaglutide trial data; people usually describe both indigestion and reflux that way.

Why does Wegovy cause heartburn?

Semaglutide slows how quickly your stomach empties, so food stays there longer. That's part of why you feel full sooner, and a fuller stomach for longer can mean more pressure, burping and acid moving up into the food pipe.

What makes it worse is personal: meal size, how late you eat, certain foods, lying down after eating. Your Glapp check-ins show which days heartburn is worst, which makes it easier to think back to what was different on those days.

GERD, sulfur burps and why lying down matters

When your stomach stays full for longer, acid can push past the valve at the top of your stomach (the lower esophageal sphincter) and up into your food pipe. That's acid reflux, or GERD when it happens often.

  • Classic triggers: large or late meals, lying down within 2–3 hours of eating, fatty or spicy food, coffee, alcohol and fizzy drinks.
  • Sulfur burps. Eggy-smelling burps are a common complaint on GLP-1 medicines, linked to food sitting longer in the stomach.
  • Before surgery or sedation. Because Wegovy slows stomach emptying, its prescribing information warns about the risk of breathing in stomach contents under anesthesia. Always tell your care team you're on it.

Track your Wegovy heartburn with a GLP-1 tracker app

Heartburn that seems random often isn't. A GLP-1 tracker shows you the pattern: log heartburn each day next to your Wegovy doses, and you're in control. You'll know which days after your shot it flares, how strong it gets and whether it's calming down, and you'll walk into your next appointment with facts instead of guesses.

Why Glapp? It's a top-rated GLP-1 tracker used by 100,000+ people, rated 4.8/5 on Trustpilot and the App Store, and 4.6/5 on Google Play. Glapp grew out of Reddit GLP-1 support groups and is built by developers who are GLP-1 users themselves, so most features come straight from community requests. Its features are grounded in peer-reviewed research and published clinical trial data, core tracking is free, and it works on iPhone, Android and web with your data synced across devices. Here's how to use it over your first 30 days.

Glapp does not provide medical advice or treat side effects. It shows your daily check-ins against your estimated medication levels so you have structured data to share with your prescriber.

Day 1: Start tracking your heartburn

Use Glapp's daily check-in to record heartburn or acid reflux and rate how severe it feels.

Daily entries help you see whether heartburn is getting better, getting worse or staying the same. You'll have a clear record of how you felt, without having to remember every day.

Daily check-in
Reflux · Med

Day 3: Compare symptoms with your estimated Wegovy level

Glapp estimates your medication level throughout the day using your dose and injection time. Semaglutide typically reaches its highest blood concentration 1–3 days after an injection.

Seeing your symptoms alongside this estimate helps you spot when heartburn appears within your shot cycle. As you log more days, you can look for a repeating pattern and know when to pay closer attention.

The medication level is an estimate, not a blood test, and a matching pattern does not prove what caused your symptoms.

Check-in next to estimated medication level
Reflux · Med

Day 7: See how your heartburn changes over time

Open the side-effects chart in the Progress tab and choose the period you want to review. Your daily ratings appear on a timeline, making it easier to see whether a difficult day was an isolated episode or part of a longer trend.

Progress, side-effects chart
Reflux · Low

Day 14: Look for patterns in your weekly report

Glapp's weekly progress report brings your logged data together, with dedicated sections showing your side effects and how they change.

Does heartburn tend to return on the same day after your shot? Does it coincide with changes in hunger or food noise? Reviewing two weeks of entries can help you spot patterns that are easy to miss day by day, and give you specific questions to discuss with your doctor.

Weekly progress report
Reflux · Low

Day 30: Bring a clear record to your doctor

After a month, review the bigger picture: is heartburn becoming less frequent, staying the same or getting worse? Semaglutide generally reaches a steady repeating level after about four to five weeks of weekly injections at the same dose.

Create a doctor's report in Glapp and choose the information to include. Your doctor can review your symptom history alongside your doses and progress, giving you a more focused conversation about your treatment.

Doctor's report

Start tracking your Wegovy heartburn in Glapp

Wegovy heartburn and dose increases: from 0.25 mg to 2.4 mg

Wegovy starts at 0.25 mg once weekly and steps up every four weeks: 0.5 mg, 1 mg, 1.7 mg, then 2.4 mg maintenance from week 17. Wegovy's prescribing information also allows a higher 7.2 mg dose for some adults. The semaglutide trial figures for these symptoms are at 2.4 mg and aren't broken down by step.

Your weekly progress report shows whether heartburn changed after a step.

See every dose in the Wegovy dosage chart.

What to bring to your prescriber

A simple log shows your prescriber the pattern at a glance:

Week Dose Heartburn days Strongest day after shot Peak rating Other side effects logged
Example 1 1 mg4Day 2HighBelching, nausea
Example 2 1 mg3Day 3MedBelching
Example 3 1 mg2Day 2MedNone
Example 4 1 mg1Day 2LowNone

Questions you could ask. They're conversation starters, not recommendations; your prescriber decides what, if anything, to change.

  • "My heartburn is strongest two days after my shot. Is that expected on Wegovy?"
  • "Can I take an antacid or other reflux medicine with Wegovy?"
  • "At what point would heartburn change how we approach my next dose step?"

Frequently asked questions

Does Wegovy cause acid reflux?

Yes. 5% of adults on Wegovy had acid reflux in the weight-loss trials, compared with 3% on placebo, and 9% had indigestion, compared with 3%.

Does Wegovy cause burping or sulfur burps?

Burping was reported by 7% of adults on Wegovy vs under 1% on placebo. The trials don't describe the smell.

Can Wegovy cause gastritis?

Gastritis was reported by 4% of adults on Wegovy vs 1% on placebo.

How do I track Wegovy heartburn?

Log it in Glapp's daily check-in and rate it low, medium or high. Glapp shows each rating next to your estimated medication level, so you can see whether it follows your shot.

About the data

Ratings are self-reported and medication levels are estimated from dose and timing, not measured. This page is for information only and is not medical advice; talk to your prescriber about any side effect.

About the author

We're GLP-1 patients and health tech professionals, building Glapp in collaboration with doctors. About us

Sources